FDG-PET/CT in re-staging of patients with non Hodgkin lymphoma and monitory response to therapy in Egypt
ConclusionFDG PET-CT significantly improved sensitivity and specificity in restaging of NHL and therefore should be used routinely in follow up of patients with lymphoma.
Source: The Egyptian Journal of Radiology and Nuclear Medicine - Category: Nuclear Medicine Source Type: research
More News: Chemotherapy | Egypt Health | Hodgkin's Disease | Lymphoma | Non-Hodgkin's Lymphoma | Nuclear Medicine | Radiology | Study